Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
Shiseido Company: Event-Driven Snapshot
Shiseido Company (TSE:4911) has drawn investor attention after recent share price moves, with the stock showing a 13.4% gain over the past month and a modest 0.5% rise over the past 3 months.
See our latest analysis for Shiseido Company.
The recent 13.4% 1 month share price return and 15.6% year to date share price return contrast with a 3 year total shareholder return of about a 59.3% loss. This suggests improving short term momentum against a weak longer term record at around ¥2,669.5 per share.
If Shiseido's rebound has you rethinking where growth might come from next, it could be a moment to scan healthcare stocks for other ideas in the wider health and beauty space.
With the share price up recently and trading around ¥2,669.5, and with an estimated intrinsic discount of about 29%, the key question is simple: is Shiseido still undervalued or is the market already pricing in future growth?
Most Popular Narrative: 38.3% Overvalued
The most followed narrative marks fair value for Shiseido Company at about ¥1,930.6 per share, which sits well below the last close of ¥2,669.5. This puts the current rally in a different light for anyone focused on long term return potential.
Structural reforms and aggressive cost reduction measures have been the primary drivers behind recent profit improvements, rather than underlying sales growth. As top-line remains flattish and key regions such as Japan, Americas, and Travel Retail continue to show weakness, the sustainability of net margins is extremely vulnerable if cost savings plateau, posing significant downside risk to long-term profitability.
Curious how an earnings recovery case can still point to a lower fair value than today's price, with only modest revenue growth and slim margins baked in, and what profit multiple needs to be justified for that to stack up, especially once those future cash flows are pulled back using a specific discount rate?
Result: Fair Value of ¥1,930.6 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are still a couple of wildcards that could challenge this bearish view, especially if cost reforms continue to support margins and China's prestige beauty demand holds up better than feared.
Find out about the key risks to this Shiseido Company narrative.
Another Angle On Valuation
That 38.3% overvaluation signal from the narrative model sits awkwardly next to another view. Our DCF model, which prices Shiseido at about ¥3,747.94 per share, suggests the current ¥2,669.5 level is trading at a meaningful discount instead. Which story do you think fits the business better?
Look into how the SWS DCF model arrives at its fair value.
Build Your Own Shiseido Company Narrative
If you look at these numbers and come to a different conclusion, or simply want to run the figures yourself, you can build a custom view in just a few minutes with Do it your way .
A great starting point for your Shiseido Company research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
Looking for more investment ideas?
If Shiseido has sharpened your thinking, do not stop here. The Simply Wall St Screener can help you quickly surface fresh ideas across very different themes.
-
Spot potential value plays early by checking out these 874 undervalued stocks based on cash flows that may be trading below what their cash flows suggest.
-
Explore companies involved in artificial intelligence by scanning these 23 AI penny stocks that are building businesses around AI applications.
-
Target income-focused opportunities by filtering for 3%","yLinkElement":"context_link","yModuleName":"content-canvas","yTrafficOrigin":"content-canvas default"}" rel="noopener noreferrer nofollow">these 14 dividend stocks with yields > 3% that might suit a yield-oriented portfolio.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include 4911.T .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
